Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tromboz, Gemostaz i Reologiya is Scopus-indexed (Q4, CiteScore 0.5). Published by Hemostasis and Rheology LLC.
Checked against the index lists dated .
ISSN 2078-1008Verify ISSN ↗2687-1483Verify ISSN ↗
Publisher: Hemostasis and Rheology LLC
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 46 / 57 | 20th | Q4 |
| Hematology | 132 / 151 | 12th | Q4 |
| Biochemistry (medical) | 71 / 78 | 9th | Q4 |
| Physiology (medical) | 112 / 117 | 4th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–2025, best quartile Q4, CiteScore 0.5.
Tromboz, Gemostaz i Reologiya is Q4 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 46 of 57), Q4 in Hematology (rank 132 of 151) and Q4 in Biochemistry (medical) (rank 71 of 78), by CiteScore 2025. It is ranked in 4 subject areas in all.
Tromboz, Gemostaz i Reologiya is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.5, quartile Q4, 20th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.178, quartile Q3, with an H-index of 5.
Tromboz, Gemostaz i Reologiya is published by Hemostasis and Rheology LLC. Its print ISSN is 2078-1008 and its online ISSN is 2687-1483.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Tromboz, Gemostaz i Reologiya has an h-index of 5 and a 2-year mean of 0.11 citations per paper (OpenAlex). Its Scopus CiteScore is 0.5, quartile Q4. On 2-year citations it ranks #49 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Tromboz, Gemostaz i Reologiya published 50 papers in 2025; its busiest recent year was 2020 with 51. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from Russia (96.9%), Algeria (1%) and Iraq (1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.